The use of functionalization applied to nanobiotechnology:Targeting cancer stem cells and regioselective functionalization of phages by Piñol Domingo, Carlos et al.
  
 
 
 
FINAL MASTER PROJECT 
Master: Nanostructured Materials for Nanotechnological Applications 
 
THE USE OF FUNCTIONALIZATION APPLIED TO 
NANOBIOTECHNOLOGY: Targeting cancer stem cells and 
regioselective functionalization of phages 
 
 
 
Carlos Piñol Domingo 
 
                         THE USE OF FUNCTIONALIZATION APPLIED TO NANOBIOTECHNOLOGY: Targeting cancer stem cells and 
regioselective functionalization of phages 
 
CARLOS PIÑOL DOMINGO Page 2 
 
 
 
 
 
 
FINAL MASTER PROJECT 
Master: Nanostructured Materials for Nanotechnological Applications 
 
THE USE OF FUNCTIONALIZATION APPLIED TO 
NANOBIOTECHNOLOGY: Targeting cancer stem cells and 
regioselective functionalization of phages 
 
 
■ STUDENT:  
▪ Carlos Piñol Domingo 
 
■ CERTIFY: 
♦ DIRECTOR: 
▪ Dr. Gerardo F. Goya Rossetti_Condensed Matter Physics department (INA), Spain. 
♦ CO-DIRECTORS: 
▪ Dr. María Carmen Visus Miguel_Patology department, (Hillman Cancer Center-
UPCI), Pittsburgh, USA. 
▪ Dr. Eric Grelet_Self-Organization of Liquid crystals department (CRPP-CNRS), 
Bordeaux, France. 
 
 
Science Faculty / University of Zaragoza 
2012 
 
                         THE USE OF FUNCTIONALIZATION APPLIED TO NANOBIOTECHNOLOGY: Targeting cancer stem cells and 
regioselective functionalization of phages 
 
CARLOS PIÑOL DOMINGO Page 3 
 
 
INDEX 
 
► GENERAL ABSTRACT …………………………………………………………………………..… 5 
 
► RESUMEN GENERAL …………………….……………………………………………………….. 7 
 
I.   GENERAL INTRODUCTION ………………………………………………..………………… 9 
1.- Nanobiotechnology ………………..…………………………..………………………………..….. 9 
2.- Nanoparticles and nanofunctionalization ………………………..……………………………..… 10 
 
• Bibliography ……………………………………………………………………………………………….. 10 
 
II. EXAMPLE 1: Targeting Cancer Stem Cells with antibody-functionalized magnetic 
nanoparticles for magnetic hyperthermia …………………………………………………...… 12 
 
1.- INTRODUCTION …………………………………………………………………………….. 12 
1.1.- Cancer …………………………………………………………………………………… 12 
1.2.- Cancer Stem Cells (CSCs): Concept, tumor cell lines and markers ………..…………… 12 
1.3.- Magnetic nanoparticles (MNPs) as agents for hyperthermia ………………….………… 14 
 
2.- AIMS ………………………………………………………………………………..………… 16 
 
3.- EXPERIMENTAL SECTION ……………………………………………………….……….. 16 
3.1. Material …………………………………………………………………………………… 16 
3.2. Protocols ……………………………………………………………………………..…… 17 
3.2.1.-  MTT protocol for cytotoxicity studies …………………………………………………….. 17 
3.2.2.- Protocol for studying the affinity between MNPs and tumor cell lines ……………………. 17 
3.2.3.- Protocol for TEM/EDX sample preparation …………………………..…………………… 18 
3.2.4.- Protocols for the studies both the interaction between MNPs:anti_CDs and the targeting of 
CSCs with these antibody-functionalized MNPs …………………………………...……… 18 
3.2.4.1.- Protocol for spectrofluorometer sample preparation …………………….……….. 19 
3.2.4.2.- Protocol for sample preparation for fluorescence microscopy …………………… 19 
 
4.- RESULTS AND DISCUSSION ……………………………………………………..……….. 20 
4.1.- Cytotoxicity studies of the MNPs on the tumor cell lines by MTT essay ………...…….. 20 
4.2.- Study of the affinity between MNPs and tumor cell lines ………………………...…….. 21 
4.3.- Study of the surface and intracellular distribution of the MNPs treated-tumor cells by 
TEM/ EDX techniques ……………………………..…………….……………………… 22 
4.4.- Fluorescence microscopy studies of the interaction between MNPs:anti_CDs and the 
targeting of CSCs with these antibody-functionalized MNPs …………………………… 23 
 
5.- CONCLUSIONS ……………………………………………………………………………… 28 
 
• Bibliography ……………………………………………................……………………………………… 29 
▫ Acknowledgements ………………………………………………………………………………………... 30 
 
III. EXAMPLE 2: Regioselective control of molecular nanoprobes on filamentous virus particles 
and self-assembly of these functionalized rod-like nanoparticles ……………………………. 31 
 
1.- INTRODUCTION ………………………………………………….…………………………. 31 
1.1.- M13 bacteriophage: wild type and mutant virus ………………………………………… 31 
1.2.- Liquid crystalline organization ………………………………………………………….. 32 
1.3.- Applications of the virus-based hybrid materials ………………………...…………….…… 33 
 
                         THE USE OF FUNCTIONALIZATION APPLIED TO NANOBIOTECHNOLOGY: Targeting cancer stem cells and 
regioselective functionalization of phages 
 
CARLOS PIÑOL DOMINGO Page 4 
 
2.- AIMS ……………………………………………………………………….…………………. 34 
3.- EXPERIMENTAL SECTION …………………………………………….………………….. 34 
3.1.- Precautions …………………………………………………………….………………… 35 
3.2. M13-C7C amplification process ………………………………………………………….. 35 
3.3.- M13-C7C titration process ………………………………………….…………………… 35 
3.4.- Functionalization process …………………………………………….………………….. 35 
 
4.- RESULTS AND DISCUSSION ……………………………………………………………… 36 
4.1.- Biology …………………………………………………………………...……………… 36 
4.2.- Chemistry ……………………………………………………………….……………….. 38 
4.3.- Physics …………………………………………………………………..……………….. 39 
 
5.- CONCLUSIONS ……………………………………………………………………………… 40 
• Bibliography ……………………………………………………………………………………………….. 41 
 
▫ Acknowledgements ……………………………………………………………………………..…………. 42 
 
IV. GENERAL CONCLUSIONS …………………………………………………………..……… 43 
 
○ ABBREVIATIONS …………………………………………………………………………………….……… 45 
 
■ APPENDIXES_EXAMPLE 1 ……………………………………………………………………………….. 47 
▪ Protocols for working with tumor cells ………………………………………………………..…………………….. 47 
▪ Fluorescence images of the cytotoxicity essays ………………………………………………..……………………. 49 
▪ Fluorescence images of the SH-SY5Y tumor cell line ……………………………………………………………… 51 
 
■ APPENDIXES_EXAMPLE 2 …………………………………………………………….…………………. 52 
▪ Basic protocols for working with phages ……………………………………………………………………………. 52 
▪ Photos taken during the course of the project ………………………………………………………………………. 53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                         THE USE OF FUNCTIONALIZATION APPLIED TO NANOBIOTECHNOLOGY: Targeting cancer stem cells and 
regioselective functionalization of phages 
 
CARLOS PIÑOL DOMINGO Page 5 
 
► GENERAL ABSTRACT 
This work, composed of two subprojects, has been developed within the framework 
of two independent research lines on the functionalization and application of nanoprobes to 
nanobiotechnology field, specifically in biomedicine or biotechnology. The multidisciplinary 
research proposal involves physicists, chemists, biochemists and medical doctors, and 
therefore a part of the student’s training work was performed at several centers abroad: The 
Hillman Cancer Center (UPCI), Pittsburgh, USA; the Centre de Recherche Paul Pascal 
(CRPP), Bordeaux and the Institut National de la Recherche Agronomique (BFP-IBVM), 
Villenave d’Ornon, France. 
Example 1. The Cancer Stem Cell (CSCs) concept says that only a small proportion of cells 
within the tumor have tumorigenic capacity. These cells are usually chemo and radio 
resistance that is why it is believed that are responsible for tumor relapse and recurrence of 
cancer patients. There is an urgent need to develop cancer therapies that are effective in 
killing these specific tumor cells. Magnetic nanoparticles (MNPs), functionalized with 
specific monoclonal antibodies, can be generated to recognize CSCs target molecules within 
the tumors. Hyperthermia is a new approach of using these MNPs positioned in an alternating 
magnetic field (AMF) to produce localized heat and kill CSCs. Magnetic nanoparticles-
induced hyperthermia is under investigation in different clinical trials on cancer patients. 
However, there is no information available on whether hyperthermia can eliminate CSCs. 
Therefore, the final goal of this project involve the application of hyperthermia to destroy 
CSCs and study the effect of this treatment in reducing tumor growth, increased cell death and 
improving the response to conventional therapies as chemo-radio therapy. 
More particularly, this work has focused on the first steps of this strategy related to 
the preparation of antibody-functionalized MNPs (MNPs:anti-CDs) and their application to 
target CSCs for several tumor cell lines by fluorescence microscopy. It has also been 
supplemented with cytotoxicity studies by MTT assays and surface and intracellular 
distribution studies by scanning electron microscopy (SEM) technique.  
Example 2. It is known that elongated viruses in concentrated solution self-organize into 
liquid-crystalline structures (mesophases) which exhibit different intermediate states between 
disordered liquids and perfectly organized crystals. Therefore, the introduction of specific 
functions by molecule grafting or nanoparticle bonding on the viral particles with a precise 
positional control, combined with the self-assembly properties of these functionalized 
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bioparticles, would give access to a wide range of applications in biosensing, memory 
devices, nanocircuits, light-harvesting systems, nanobatteries or MRI contrast agents. We 
used the mutant M13-C7C phage which presents a genetic mutation that allows the creation of 
unique binding sites on only one end of the filamentous virus through a pair of cysteine 
residues. The final goal of the project is to develop hybrid materials formed by the monitored 
assembly of these mutant M13-C7C phages with magnetic nanoparticles, with a 1:1 molar 
ratio, to induced highly sensitive nanorods by magnetic field, which are otherwise absent 
from the viral coat protein of the wild type phage. 
More specifically, this work has focused in the mass production, amplification and 
purification processes, of the mutant M13-C7C phage which is during its growth in 
competition with the wild type one. We have then specifically studied the functionalization of 
these mutant phages with maleimide fluorophores, followed by the self-organization 
properties in order to validate our scientific approach. 
• Keywords: Nanobiotechnology; Nanofunctionalization; Cancer stem cells (CSCs); Magnetic 
nanoparticles (MNPs); Monoclonal antibodies; Viral nanoparticles (VNPs); Liquid crystalline 
structures. 
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► RESUMEN GENERAL 
Este trabajo, compuesto de dos subproyectos, se ha desarrollado en el marco de dos 
líneas de investigación independientes en la funcionalización y aplicación de nanosondas en 
el campo de la nanobiotecnología, específicamente en biomedicina o biotecnología. La 
propuesta de investigación multidisciplinar implica físicos, químicos, bioquímicos y médicos, 
y por lo tanto una parte del trabajo de formación del estudiante se realizó en varios centros en 
el extranjero: el Hillman Cancer Center (UPCI), Pittsburgh, USA; el Centre de Recherche 
Paul Pascal (CRPP), Bordeaux y el Institut National de la Recherche Agronomique (BFP-
IBVM), Villenave d’Ornon, Francia. 
Ejemplo 1. El concepto de célula Madre del Cáncer (CMC) dice que sólo una pequeña 
proporción de células dentro del tumor tienen capacidad tumorigénica. Estas células son 
normalmente quimio y radio resistentes, y es por lo que se cree que son responsables de la 
recaída y reaparición del tumor de pacientes con cáncer. Hay una necesidad urgente en 
desarrollar terapias contra el cáncer que sean efectivas en matar CMCs. Nanopartículas 
magnéticas (NPMs), funcionalizadas con anticuerpos monoclonales específicos, pueden ser 
generadas para reconocer moléculas diana de CMCs dentro de tumores.  La Hipertermia 
Magnética (HTM) es un nuevo enfoque en utilizar las nanopartículas magnéticas (NPMs) 
posicionadas en un campo magnético alterno para producir calor localizado y matar las 
células tumorales. La hipertermia (HT) inducida mediante nanopartículas está bajo 
investigación en diferentes ensayos clínicos en pacientes con cáncer. Sin embargo no hay 
información disponible de sí la HT puede eliminar CMCs. Por lo tanto, el objetivo final de 
este proyecto implica la aplicación de la HT para destruir CMCs y estudiar el efecto de este 
tratamiento en reducir el crecimiento del tumor, aumentando la muerte celular y mejorando la 
respuesta a terapias convencionales como la quimio-radio terapia.  
En concreto, este trabajo se ha centrado en los primeros pasos de esta estrategia, 
relacionadas con la preparación de NPMs funcionalizadas con anticuerpos específicos 
(NPMs:anti-CDs) y su aplicación en el marcaje de CMCs para varias lineas celulares 
tumorales mediante microscopía de fluorescencia. También se ha complementado con 
estudios de citotoxicidad mediante ensayos de MTT y estudios de la distribución intracelular 
mediante la técnica de microscopía electrónica de barrido (MEB). 
Ejemplo 2. Es conocido que los virus elongados en soluciones concentradas se auto-
organizan en estructuras de cristales líquidos las cuales exhiben diferentes estados 
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intermedios entre líquidos desordenados y cristales perfectamente organizados (mesofases). 
Por lo tanto, la introducción de funciones específicas mediante el injerto de moléculas o la 
adhesión de nanopartículas en las partículas virales con un control posicional preciso, 
combinadas con las propiedades de auto-ensamblado de estas biopartículas funcionalizadas, 
podría dar acceso a un amplio rango de aplicaciones en biosensores, dispositivos de memoria, 
nanocircuitos, sistemas acumuladores de luz, nanobaterías o agentes de contraste para MRI. 
Nosotros usamos el fago mutante M13-C7C el cual presenta una mutación genética que 
permite la creación de sitios de unión únicos exclusivamente en un extremo del fago, a través 
de un par de residuos de cisteína. El objetivo final del proyecto es desarrollar materiales 
híbridos formados por el ensamblado controlado de estos virus mutados M13-C7C con 
nanopartículas magnéticas (NPMs), con un relación molar 1:1, para inducir nanovarillas 
(nanorods) altamente sensibles mediante campos magnéticos, los cuales están por otra parte 
ausentes en la proteína de la cubierta viral de el fago de tipo silvestre. 
Más concretamente, este trabajo se ha centrado en los procesos de producción en 
masa, amplificación y purificación, del fago mutado M13-C7C el cual está durante su 
crecimiento en competición con el tipo salvaje. Después hemos estudiado específicamente la 
funcionalización de estos fagos mutantes con fluoróforos de maleimida, seguido de las 
propiedades de auto-organización para tratar de validar un enfoque científico. 
• Palabras clave: Nanobiotecnología; Nanofuncionalización; Células madre del cáncer (CMCs); 
Nanopartículas magnéticas (NPMs); Anticuerpos monoclonales; Nanopartículas virales (NPVs); 
Estructuras cristalinas líquidas. 
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I. GENERAL INTRODUCTION 
1. Nanobiotechnology 
Nanobiotechnology (bionanotechnology or nanobiology), a mix between 
nanotechnology and biotechnology, is extensively interdisciplinary because it combines 
physical principles, chemical properties, and biological characteristics. The great promise of 
nanobiotechnology stems from our burgeoning ability to design and synthesize self-
assembling biostructures with better functionality, sensitivity, and specificity than synthetic 
organic or inorganic molecules [1]. This intersection of research fields is based on the 
perception that nanotechnology can offer biology new tools with a depth of understanding, 
while biological principles guide nanotechnology to new forms of highly complex functional 
nanosystems. Biological systems can guide the physical world of electronics, materials 
science, computation, and manufacturing in the assembly of complex functional devices and 
systems operating at the molecular and even atomic level [see the FIG. 1] [2]. 
Nanomedicine is one of the fastest moving and most exciting research areas is the 
interface between nanotechnology, biology and medicine. This field presents many exciting 
possibilities for healthcare offering nanostructures as new therapeutic alternatives, which 
could revolutionize the areas of targeted/controlled drug delivery, disease detection, magnetic 
hyperthermia applied to cancer, biosensors or tissue engineering, and so on [3]. Another 
emerging and highly interdisciplinary field is Viral Nanotechnology, inhabiting the interface 
between virology, chemistry and materials science, in which viral nanoparticles (VNPs) are 
applied in diverse areas such as electronics, energy and next-generation medical devices [4,5]. 
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2.- Nanoparticles and nanofunctionalization 
Nanotechnology has brought a new generation of lightweight materials with superior 
mechanical and electrical properties [6]. An important example is the nanoparticle (NP), 
which is an excellent candidate for their further application in nanobiotechnology [7]. It is 
crucial to develop procedures for their adequate biofunctionalization, which ultimately 
confers the appropriate features for biotechnological and biomedical applications, such as 
specificity and bioactivity. Therefore, different strategies have been reported for their 
functionalization with relevant biomolecules such as antibodies, viruses, peptides, folic acid, 
vitamins, antibiotics DNA, carbohydrates, etc. [8, 9]. 
The immobilization of biologically active molecules requires low density and good 
steric accessibility to active binding sites of the NPs [10]. Some examples of different 
immobilization protocols (nanofunctionalization process) are through non-covalent 
interactions, such as using exclusively electrostatic interactions (the most simple strategy), via 
immobilized protein A (presents high affinity to the Fc region of most ABs), through biotin-
avidin/Streptavidin (the strongest known non-covalent biological interaction), or also by 
maleimide-thiol reaction (via covalent bonding assembly) [see the FIG. 2] [11, 12, 13]. 
 
Two examples of the use of the functionalization applied to nanobiotechnology are 
reviewed in this report. In the first case, we will target cancer stem cells with antibody-
functionalized magnetic nanoparticles for magnetic hyperthermia. The regioselective control 
of molecular nanoprobes on filamentous virus particles and self-assembly of these 
functionalized rod-like nanoparticles will be considered in the second case. 
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II. EXAMPLE 1: Targeting cancer stem cells with antibody-functionalized magnetic 
nanoparticles for magnetic hyperthermia 
 
1. INTRODUCTION 
1.1. Cancer 
Cancer remains as one of the most leading causes of death [1]. Based on the 
GLOBOCAN 2008 estimates about 12.7 million cancer cases and 7.6 million cancer deaths 
occurred in 2008, accounting for 13% of all human deaths worldwide [see the FIG. 1]. 
Cancer concept encompasses a broad group of diseases, all of them involving 
unregulated cell growth, in which cells divide and grow uncontrollably, forming malignant 
tumors and eventually have the potential to metastasize. Nowadays, the most common types 
of cancer treatments available are chemotherapy, surgery and radiotherapy  [2]. 
 
1.2. Cancer Stem Cells (CSCs): Concept, tumor cell lines and markers 
What cells can be transformed to form tumors? To answer this central question in 
cancer biology was proposed the stochastic model. This theory believed for a long time hold 
that any tumor cell, uniform from a biological standpoint, can lead to new cancer [see the 
FIG. 2, A) (left)]. Unfortunately, this model seems to fail because the active programs 
responsible for the malignant process (tumor regeneration) are unlikely. Besides, experiments 
conducted during the last decades have shown that it is necessary up to a million human 
tumor cells or mouse to establish a tumor. Therefore, a new theory has recently emerged. This 
is the hierarchical theory that suggests that tumor cells are heterogeneous from a functional 
point of view and could be organized in a hierarchy where there are a minority population 
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within the tumor cell mass in each type of cancer, the CSCs, constituting the bulk of the 
cancer cells within the tumor in most cases [see the FIG. 2, A) (right)]. These “tumor 
initiating cells” have characteristic properties both of normal stem cells, such as capacity of 
self-renew and the potential to divide asymmetrically generating any cell type within the 
tumor; and also of tumor cells, dividing uncontrollably (a large number of times) and leading 
the expansion of the tumor. Given its properties, it has been postulated that the CSCs may 
arise from mutations in normal stem cells, which are found in many tissues. In some cases, 
these CSCs may be very resistant reservoirs to radiotherapies and chemotherapies, being 
responsible for the relapse of a tumor (reappearance frequently observed in many cancers) or 
even give rise to metastases [see the FIG. 2, B)]. Therefore, since conventional therapies 
often increase the fraction of tumorigenic cells in cancer, the experimental results suggest that 
only those treatments capable of eliminating the CSCs may prevent an effective and lasting 
recurrence [3-6]. 
 
 
Recently, putative CSCs have been discovered in many different solid tumor types. 
Examples include the Head and Neck Squamous Cell Carcinoma (SCCHN) cell line PCI-13, 
an epithelial tumor with hardly any improvement in the treatment during the last 30 years, 
containing about < 10 % of CSCs within the tumor [7 - 9]. Breast cancer cell line MDA-MB-
231, also an epithelial tumor where the CSCs, discovered in 2003, are representing only 2% 
of the total mass of breast tumor cells [10, 11]. The human neuroblastoma cell line SH-SY5Y, 
the most commonly diagnosed tumor in infants, with a population of CSCs appears to 
represent between 0.3% and 25.1% of the tumors examined [9]. Also, recently it has been 
discovered CSCs of the pancreatic cancer cell line MIA PaCa-2, a lethal epithelial tumor 
usually diagnosed in an advanced state [12, 13]. 
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How have the CSCs been identified? Thanks to a variety of markers expressed by the CSCs 
(CSCs markers) such as cell-surface proteins (CD133, CD44, CD34), cytoplasmic proteins 
(ABC transporters) and enzymes (Aldehyde dehydrogenase [ALDH1]) and so on. It must be 
taken into account that the vast majority of cells, which express these markers, are not stem 
cells and the markers considered from one organ are frequently not useful for identifying stem 
cells in other tissues [6]. The combination of these markers, for instance CD133 and CD44, 
two star markers, is believed that could be specific CSCs markers for many tumors [4]. On the 
one hand, CD133, a glycosylated transmembrane cell surface antigen with unknown function 
so far, is restricted to stem cells since is considered an early (proliferative) antigen expressed 
on primitive progenitors (such as pancreatic islet cells or placenta) and some leukemias [14-
16]. It has been found that this marker labels CSCs of brain (e.g. SH-SY5Y 2.7%), prostate, 
intestinal, pancreatic, ovarian, colorectal, lung and liver cancers [17]. On another hand, CD44, 
a highly glycosylated type-I transmembrane cell surface receptor protein involved in 
cell/matrix interactions, is widely expressed on most cell types. This CSC marker is typically 
expressed in breast, colorectal, ovarian, liver, SCCHN or pancreatic cancers [4, 14]. 
1.3. Magnetic nanoparticles (MNPs) as agents for hyperthermia 
MNPs are submicron moieties with special magnetic properties, made of inorganic 
or organic materials, which may or may not be biodegradable [18]. MNPs for biomedical 
applications must be highly stable over time, unrecognizable by the immune system (with 
biocompatible polymers), have low levels of toxicity and a high magnetic moment which 
minimizes the required doses [19]. The iron-based NPs (mainly magnetite, Fe3O4) have 
provided today the best results in relation to its cytotoxicity and final biodistribution in the 
body [1, 20, 21]. A useful method in cytotoxicity studies, very simple, accurate, yields 
reproducible results, is the MTT essay, which consists of viable (living) cell determination 
spectrophotometrically as a function of mitochondrial activity in living cells. Compared to 
conventional therapies, nanoparticles (NPs) show several advantages in cancer treatment (or 
diagnosis) due to they can be synthesized in specific sizes (10-100 nm) and with surface 
characteristics to penetrate tumours. Besides, they can also be engineered to penetrate cells 
and physiological barriers or to target tumour cells (surface functionalization) with 
biomolecules by attaching to tumor-specific cell markers. 
Magnetic Hyperthermia (MHT), one of the promising approaches in cancer therapy 
[22], consists of heating the target tissue (44 < T < 46 º C), by remote application of an 
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alternating magnetic field applied on previously incorporated MNPs to CSCs. The purpose of 
this non-invasive and highly selective technique is to inhibit the proliferation of CSCs with 
the aim of destroying or rendering them more sensitive to the effects of conventional 
protocols of radiation and chemotherapy [23, 24]. A significant improvement in clinical 
outcome with improved overall survival, as compared to patients who only receive 
radiotherapy or chemotherapy, has been demonstrated for tumors of the SCCHN, breast, 
brain, and so on [25, 26]. Certainly this technique depends on the efficiency to transport the 
MNPs into the CSCs (target cells) to be heated, so that a central part of this technique is to 
implement an effective strategy for vectorization of these NPs. A good choice is to use of the 
monoclonal antibodies (ABs or anti-CDs) (other options are carbohydrates, peptides or 
nucleic acids) to recognize different CSCs markers, thanks to their unique properties which 
there are sensitivity, selectivity and specificity [27] [see the FIG. 3].  
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2. AIMS 
Several experiments designed to achieve the targeting of CSCs with MNPs, 
previously functionalized with anti-CDs, are reviewed in this work: 
-  To determine the cytotoxicity of the Magnetic Nanoparticles (MNPs) on the tumor cell 
lines. Cytotoxicity studies will be carried out for each line by MTT essays, modifying the 
concentration of nanoparticles (NPs) and the times of incubation. 
-  To study the surface and intracellular distribution of the NPs treated-tumor cells. It 
will carry out the incubation of the tumor cells lines with the MNPs, analyzing both the 
affinity between MNPs and tumor cells by Neubauer chamber counting and also the 
intracellular distribution of the cancer cells by Scanning Electron Microscopy (SEM). 
-  To functionalize the MNPs with specific anti-CDs and CSCs targeting. The synthesis of 
the fully functional MNPs with highly specific markers, anti-CD44 and anti-CD133, and 
the characterization of the resulting complex (MNPs-anti_ABs) in terms of stability and 
functionality,  with the targeting of CSCs, will be studied by fluorescence microscopies. 
 
3. EXPERIMENTAL SECTION 
3.1. MATERIAL [see the FIG. 3] 
▪ Magnetic nanoparticles (MNPs). Monodisperse MNPs with a particle size of 40 nm, 
composed of a Fe3O4 core and PEI shell, were used.  
▪ Tumor cell lines. Four tumor cell lines have been used throughout the life of this project. 
On the one hand, SCCHN cell line PCI-13, breast cancer cell line MDA-MB-231 and 
pancreatic cancer cell line MIA PaCa-2 were used during the stay in the Hillman Cancer 
Center. These cell lines were either established at the University of Pittsburgh Cancer 
Institute. On the other hand, human neuroblastoma cell line SH-SY5Y, a cell line established 
at the Institute of Nanoscience of Aragón (INA), was used during the stay in the INA. 
▪ Monoclonal antibodies (ABs or anti-CDs). It has worked with two monoclonal antibodies: 
▫ CD44 (HI44a) – FITC Antibody, human. [Clone: HI44a (isotype: mouse IgG2a), 
purchased from MACS Miltenyi Biotec]. This CD44 antibody (anti-CD44), conjugated to 
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Fluorescein isothiocyanate (FITC), anti-CD44_FITC, recognizes an epitope of the CD44 
antigen.  
▫ CD133/1 (AC133) – PE antibody, human [Clone AC133 (isotype: mouse IgG1), purchased 
from MACS Miltenyi Biotec]. This CD133 antibody (anti-CD133), conjugated to R-
phycoerythrin (PE), anti-CD133_PE, recognizes an epitope of the CD133 antigen. 
 
3.2. PROTOCOLS 
▫ Note: In the APPENDIX 1 are shown some protocols when working with tumor cells. 
3.2.1. MTT protocol for cytotoxicity studies. 
DAY 1 – The tumor cells were seeded onto three 96-well plates (a plate for each essay time) at 
106 cells mL-1 (105 cells per well). Each plate contained three-quarter parts of the wells with 
the three tumor lines, corresponding to a quarter for each one; and the last quarter of every 
plate without cells (only growth medium), used as a negative control. 
DAY 2 – 100 µL of MNPs medium at different concentrations were added to each one of the 
wells. Seven different concentrations, for each line of the plate, ranged from 1 to 200 µg 
MNPs mL-1 medium (1, 2, 5, 10, 50, 100 and 200 µg MNPs mL-1 medium), and the last line 
without MNPs used as a negative control (prepared in triplicate). These samples were cultured 
overnight at 37ºC. 
DAY 3, 4 and 5 – The following procedure was repeated with the pertinent plaque for each 
time. To perform the colorimetric test, 100 µL of medium of each well were removed gently, 
incubating the samples with 10 µL (5 mg mL-1) MTT at 37ºC for 3h. The resultant formazan 
crystals were dissolved in 100 µL of lysis buffer. The absorbance was measured by a 
microplate reader (ELISA) at 550 nm. An important aspect to take in account is the removal 
of any bubbles to avoid interferences in the measurements. 
3.2.2. Protocol for studying the affinity between MNPs and tumor cell lines. 
DAY 1 – Three cell culture flasks for every tumor cell line containing 6.7 x 105 tumor cells 
each of them (1.34 x 105 cells mL-1) were prepared. Subsequently, 15 µL of MNPs (10.32 µg 
mL-1) were added into two of the three replicates. The last one was used like control. Then, all 
samples were incubated overnight at 37ºC. 
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DAY 2 –  The harvesting and the counting of tumor cells lines were carried out, as are 
explained in the point protocols for working with tumor cells of the APPENDIX 1. Then, the 
samples were passed down a magnetic column (OctoMACSTM Separator, MACS Miltenyi 
Biotec), obtaining the respective flow thru of each sample. Subsequently, the magnetic 
columns were disengaged from the separator and several PBS volumes were passed down 
through to obtain the eluates. Finally, it was carried out the counting of the tumor cells, of 
both flow thru and elutes, in the same way than the last time. 
3.2.3. Protocol for TEM/EDX sample preparation. 
DAY 1 – The SH-SY5Y cells were seeded onto a 24-well plate at 5 x 104 cells mL-1 (5 x 104 
cells per well). A sterile cover slip had been added in each well used in the assay, previously. 
The tumor cells were cultured overnight at 37ºC. 
DAY 2 – Cells were washed twice with PBS and the MNPs media, at different concentration, 
were added into wells each. The first well was used as a negative control and the following to 
the well 6 contained 1.25, 2.5, 5, 25 and 25 µg MNPs mL-1 medium (two replicas). The tumor 
cells with and without MNPs were cultured overnight at 37ºC. 
DAY 3 – The growth medium of each well was removed, containing any cell that may have 
been peeled away and the MNPs that not have been incorporated or anchored into the tumoral 
cells. The samples were washed twice and afterwards fixed with 2.5% glutaraldehyde in 0.1M 
sodium cacodylate buffer with a 3% sucrosa solution for 90 min at 37ºC. After the fixation, 
the samples were re-washed twice and the dehydratation process was conducted by incubating 
the cells at RT with increasing concentrations of methanol, through following steps in 
duplicate: Firstly, MeOH 30%, 50%, 70% for 5 min each one; secondly MeOH 100% for 10 
min; and finally, MeOH 100% anhydride for 5 min. The prepared samples were preserved 
into anhydride methanol in the refrigerator at 4-8ºC, waiting for the next step.  Finally, all 
cover slips were sputter-coated with gold, remaining as intact samples until they were 
analyzed by SEM (SEM INSPECT F50, FEI Company) and EDX. 
3.2.4. Protocols for the studies both the interaction between MNPs:anti_CDs and the targeting 
of CSCs with these antibody-functionalized MNPs. 
Firstly, 10 µL of each anti-CD (or only one, depending of the sample) anti-
CD44_FITC or/and anti-CD133_PE and different ranges of MNPs concentration were added 
into each eppendorf, containing 500 µL of TRIS buffer at pH:7.9. In addition, several 
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negative controls were also prepared, where the first one corresponded to the negative control 
with only buffer (without MNPs and anti-CDs), the second one only contained 10µL of each 
anti-CD and the last one contained exclusively MNPs. These samples were stirred by vortex 
and incubated for 1 hr at RT. Secondly, magnetic separation of the samples were carried out 
using a Magnetopure size big (Chemicell). To this end, each eppendorf was inserted into the 
magnetized wells and steeping for 30 min. Finally, the supernatants were isolated and 
analyzed by spectrofluorometry on the one hand, and the pellets by fluorescence microscopy 
on the other. 
3.2.4.1. Protocol for spectrofluorometer sample preparation. 
The supernatants obtained were analyzed by spectrofluorometry, using a LS5S 
luminescence spectrometer (Perkin Elmer Life Sciences). The intrinsic fluorescence 
spectrum was monitored from 496–600 nm upon excitation at 496 nm in 0.5 cm path 
length plastic disposable cuvettes. In advance, optimization process was carried out with 
the best slit width and preparation of the standard curves for both anti-CDs and MNPs, or 
without MNPs. 
3.2.4.2. Protocol for sample preparation for fluorescence microscopy. 
DAY 1 – SH-SY5Y cells were seeded onto a 24-well plate at 105 cells mL-1 (105 cells per 
well). A sterile cover slip had been added in each well used in the assay, previously. The 
tumor cells were cultured overnight at 37ºC. 
DAY 2 – Cells were washed twice with PBS and the culture mediums containing the 
pellets related to the essay in basic media (TRIS buffer at pH=7.9) were added in each 
well. The first two wells were used as a negative control, where the first one corresponded 
to the negative control without MNPs or anti-CDs, and the second one was the negative 
control only with 10 µL of each anti-CD. These samples were cultured overnight at 37ºC. 
DAY 3 – The growth medium of each well was removed, containing any cell that may 
have been peeled away and the conjugates that not have been incorporated or anchored into 
the tumoral cells. The samples were washed twice and afterwards fixed with 4 % PFA for 
15 min at RT. After the fixation, by helping with tweezers and outside the laminar-flow, 
the cover slips were washed three times sequentially submerging into different beakers 
with the following sequence of fluids: PBS, PBS, Milli-Q. Then, the treated cover slips 
were fixed on slides. To that end, 5 µL of Mowiol-DAPI solution was added on a slide for 
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every sample and dropped carefully the cover onto the solution, trying to avoid formation 
of air bubbles between slide and cover.  
DAY 4 – Finally, each cover was fixed stronger on the cover slip with nail polish. The 
fluorescent samples must be kept in the dark to avoid any degradation. 
 
4. RESULTS AND DISCUSSION 
4.1. Cytotoxicity studies of the MNPs on the tumor cell lines by MTT essay 
The cytotoxicity produced by MNPs is an important obstacle that needs to be 
overcome for biomedical applications. Therefore, it is fundamental to determine how the 
MNPs are affecting to the viability of any type of cell inside the bloodstream. In this project 
was delimited the study for several tumor cell lines. For that, MTT cell viability assays were 
carried out to analyze the toxicity caused by the MNPs in several tumor lines (Mia PaCa-2, 
PCI-13 and MDA-MB-231) at different times; in this case, every 24 hours for three days (see 
the protocol in  previous experimental section 3.2.1.).  
 
The results showed a decreasing trend for each cell viability bar, pertaining to each 
tumor cell line, when the MNPs concentration is increased from 10 µg mL-1 to 200 µg mL-1 
[see the FIG. 4]. More specifically, there was not observed a loss of viability to 5 µg mL-1, and 
from here there were a proportionately reduction to the higher concentration studied, with a 
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net loss of cell viability around the 20 percent. There seems not to exist an obvious loss of the 
viability of tumor cell lines over time, from day 1 to 3. 
 Furthermore, these cancer cells seem to attach (or internalize, it is not clear) with 
the MNPs, as there seems shown in the fluorescence images taken during this cytotoxicity 
essay (see the photos in the Appendix 1). It was also observed the agglomeration of the MNPs, 
at high concentration, which is a problem to take into account. 
It should also be noted that if the results would have been positive, showing a toxic 
effect these MNPs for the tumour cell lines studied, the application of hyperthermia would not 
have been needed. Actually, it is fundamental to work with non-toxic MNPs because if they 
were capable to destroy very resistant cells, such as tumor cells, to kill the normal cells would 
be more very simple.  
 
4.2. Study of the affinity between MNPs and tumor cell lines 
In order to get an idea regarding the affinity between the MNPs and the tumor cell 
lines, whether or not take place their uptake, a simple essay of cell counting was carried out 
by Neubauer chamber counting (explained in the experimental section 3.2.2.) [see the FIG. 5]. 
 
The results for every tumor cell line could be three replicas of the same essay 
because of the similarity. The flow-thru, which corresponds to the cells not attached on the 
magnetic column, only show positive results for the cells without MNPs. On the contrary, 
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exclusively the population of the cells with the MNPs has been obtained in the eluates, which 
correspond to the cells attached on the magnetic column. Thanks to this experiment, it has 
been proved that practically all cells attach or internalize the MNPs for each tumor line 
studied (PCI-13, MIA PaCa-2 and MDA-MB-231). 
 
4.3. Study of the surface and intracellular distribution of the MNPs treated-tumor cells 
by TEM/EDX techniques 
We have already demonstrated that tumor cells interact with the MNPs, but it doesn’t 
know if there exists the internalization of them. Subsequently, a much more comprehensive 
study was carried out using two more powerful techniques such as Scanning Electron 
Microscopy (SEM), which provides high-resolution and long-depth-of-field images of the 
sample surface, and Energy Dispersive X-ray Spectroscopy (EDX), offering elemental 
identification of almost any element of the periodic table (explained in the experimental 
section 3.2.3.). 
Clear differences in the tumor cell surface were observed between the cultured tumor 
cells with and without MNPs [see the FIG. 7]. The blank sample, belonging to the control 
without MNPs, showed the normal morphology of these kind of cells, which is a large 
extension of the axon (that conducts electrical impulses away from the neuron's cell body), 
and the long and branched projections of the dendrites (that act to conduct the electrochemical 
stimulation received from other neural cells to the cell body). In contrast, in the case of the 
tumor cells cultured with MNPs, it was observed a reduced cell extension with much more 
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delimited cell morphology due to the presence of short dendrites even further branched. 
Furthermore, unlike the control, these samples exhibited a cell membrane filled with 
roughness. These membrane deformations seem to show that the tumor cells contain material 
inside, therefore, it is likely that the MNPs were also internalized apart from carried out the 
MNPs adhesion on the surface. These observations present the same trend with increasing 
concentration of MNPs from 5 to 25 µg mL-1. 
 
Thanks to the second technique used, EDX, it was definitely corroborated that we 
have effectively iron material in the samples, corresponding to the MNPs. Clearly, it is 
observed an expanding red spot on the tumor cells with increasing concentration of MNPs 
[see the FIG. 7]. These figures give us also information about the distribution of the carbon 
(integral element of living systems) or the silice (the SiO2 is the major component of cover 
slip) in each sample.  
These samples were also analyzed by fluorescence microscopy obtaining good 
photos (see the fluorescence images of the SH-SY5Y tumor cell line in the APPENDIX 2). 
4.4. Fluorescence microscopy studies of the interaction between MNPs:anti_CDs and the 
targeting of CSCs with these antibody-functionalized MNPs 
The goal of these essays was to optimize the conditions for achieving the maximum 
interaction between NPMs and anti-CDs, and thus reaching together the target (the CSCs) 
with the maximum guarantees. As already discussed, the labeling of MNPs with anti-CDs is a 
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crucial step for the selective and specific labeling of the CSCs within the tumor. Therefore, an 
experiment to study the interaction between MNPs and anti-CDs in different media, 
mimicking the behavior of these conjugates in hypothetical living conditions which would be 
found inside of blood stream, was designed. After doing several initial essays without 
satisfactory results, possibly because this functionalization method chosen, by electrostatic 
interactions, does not seem sufficiently consistent to take account in carrying out more 
complex essays such as when it works in PBS or cRPMI it was decided to simplify the 
experiment. In doing so, several essays working in basic conditions (TRIS buffer pH:7.9) 
were evaluated to study the affinity between MNPs:anti-CDs (explained in the experimental 
section 3.2.4.) [see the FIG. 8].  
The functionalization process was carried out by electrostatic interactions [see the 
FIG. 3], where the carboxyl groups of the FcR of the anti-CDs were made interact with the 
free amine groups on the surface of the MNPs. Both anti-CDs, anti-CD44 and anti-CD133, 
have an isoelectric point of 7.3, therefore, the carboxyl groups present negative charge for this 
pH and for more basic values. For the case of the MNPs the isoelectric point (Zeta potential) 
is 9.2, so the closer the pH value are to 9.2, the more positive charges the MNPs have on the 
surface (reason because the TRIS buffer pH:7.9 was chosen). Moreover, thanks to the 
interaction between the anti-CDs and the MNP is realized in the FcR, the Fab region is free to 
interact with the CSCs markers (fundamental step). In principle, these electrostatic 
interactions achieved will remain at the physiologic pH, 7.3 (blood conditions), disappearing 
for lower values because of the protonation of the carboxyl groups (loss of the negative 
charges). 
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Once the magnetic separation was carried out, after the incubation process between 
the anti-CDs and the MNPs, two types of samples were collected: Supernatants and pellets. 
The observation of a loss of anti-CDs in the supernatants with the resultant presence of 
them in the pellets will corroborate the affinity between the MNPs and the anti-CDs. 
Besides, the incubation of these MNPs:anti-ABs_FLU with the tumor cells will allow to 
locate the CSCs inside the tumor sample. 
 
On the one hand, the supernatant samples, containing the anti-CDs_FLU unreacted 
free from the MNPs or MNPs:anti-ABs_FLU, were obtained. According to our estimates, the 
peak intensity for each of these sample (measured by the spectrofluorometer) should be lower 
gradually, meaning a less amount of anti-CDs in the supernatant since they will have reacted 
with the MNPs, for higher values of the MNPs concentration (added during the incubation). 
This is because a higher amount of MNPs permits an increased interaction surface for the anti-
CDs. The hypothesis seems to be fulfilled in outcomes obtained in the graphic [represented in 
the FIG. 9]. Specifically, this is true for all the samples except for the sample which had been 
incubate with the highest MNP concentration. An adequate MNP concentration there might 
be, in this case around 50 µg mL-1, producing the MNPs agglomeration for higher 
concentrations and avoiding the interaction between MNPs and anti-CDs_FLU. Besides, the 
affinity between MNPs and anti-CDs seems to change slightly for anti-CD44 or anti-CD133, 
because the agglomeration effect previously described is lower in the case of the first anti-CD.  
 
                             Example 1: TARGETING CANCER STEM CELLS WITH ANTIBODY-FUNCTIONALIZED MAGNETIC 
NANOPARTICLES FOR MAGNETIC HYPERTHERMIA 
 
CARLOS PIÑOL DOMINGO Page 26 
On the other hand, the pellet samples were obtained, containing the magnetic 
species (MNPs and MNPs:anti-CDs_FLU), free from the anti-CDs_FLU unreacted. These 
pellets were also attempted to analyze by spectrofluorometry without results, possible due to a 
quenching effect by MNPs. For that, a new hypothesis was proposed, consisting to incubate 
the pellets with a tumor cell line, trying to detect the fluorophores by fluorescence 
microscopy. The results were positive, as shown in the pictures of the FIG. 10, for the case of 
the anti-CD44_FITC, but without results for anti-CD133_PE. Thanks to this essay was to 
demonstrate (only for the anti-CD44) that the interaction had occurred and, moreover, and 
conclusively proven to targeting the CSCs for the human neuroblastoma cell line SH-SY5Y 
[see the FIG 10]. The images shows some blanks prepared and the results for the pellet 
samples, 5 and 25 µg mL-1, after incubating the pellets with the tumor cell. The blue color 
present in some pictures corresponds to the DAPI which is used extensively in fluorescence 
microscopy since this is a fluorescent stain that binds strongly to A-T rich regions in DNA, 
allowing to clearly locate cells. The green color is the anti-CD44, which is present in many 
cells of every sample. Unfortunately, the anti-CD133 was not observed, even for the dynamic 
range also studied, decreasing the intensity to the minimum (extreme conditions) as shown in 
the picture 3.d of the FIG.10. 
The same experiment was repeated using a different fluorescence microscope, 
obtaining the same results (see the fluorescence images of the SH-SY5Y tumor cell line in the 
APPENDIX 2). 
Concretely, the goal was to localize specifically the CSCs at the junction of both 
anti-CDs_FLU, since neither of them alone is specific for the CSCs, but unfortunately one of 
them did not work. The causes of this problem are unknown. On the one hand, it does not 
appear to be a problem related to a loss of the fluorescence because of it was observed 
fluorescence by spectrofluorometry. On the other hand, according to the introduction, there 
exists a sub-population about the 2.7% of CSCs for the SH-SY5Y cell line, using this anti-
CD133 marker, therefore, that does not seem to be a problem related to a non-specific CSC 
marker. Therefore, the real problem might be due to a functionalization loss of the anti-
CD133. It must take into account that these anti-CDs_FLU were transported from USA to 
Spain, remain at room temperature for over 24 hrs (at the end of summer), so it is possible 
seems feasible that the anti-CD133_PE was damaged. 
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[FIG 10] FLUORESCENCE IMAGES OF THE PELLETS. Study of the interaction between 
MNPs:anti_CDs in TRIS buffer, pH:7.9. Fluorescence images of SH-SY5Y_pellets (culture medium): 
1) BLANK 1 (only cells), 10X; 1.a) Cells (DAPI). 2) BLANK 2 (cells + anti-ABs), 10X; 2.a) Cells, 2.b) 
Cells (DAPI)_anti-CD44_FITC, 2.c) Cells_anti-CD44_FITC. 3) BLANK 2 (cells + anti-ABs), 20X;  3.a) 
Cells, 3.b) Cells (DAPI), 3.c) Cells (DAPI)_anti-CD44_FITC, 3.d) Cells_anti-CD133_PE (dynamic 
range). 4) SUPERNATANT 4: 5µg mL-1, 20X; 4.a) Cells, 4.b) Cells (DAPI),4.c) Cells (DAPI)_anti-
CD44_FITC, 4.d) Cells_anti-CD44_FITC. 5) SUPERNATANT 3: 25 µg mL-1, 20X; 5.a) Cells (DAPI), 
5.b) Cells (DAPI)_anti-CD44_FITC, 5.c) Cells_Anti-CD44_FITC. Images taken by the inverted fluorescence 
microscope OLYMPUS IX81, with the help of Dr. María Royo in the microscopy and image service of the IACS (Zaragoza). 
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IV. CONCLUSIONS 
A set of experiments corresponding to the functionalization of MNPs with anti-CDs, 
and the CSCs targeting with these compounds formed, has been described. Moreover, it was 
also fundamental to obtain some preliminary information about cytotoxicity studies or the 
affinity between this kind of MNPs and the tumor cell lines studied, due to the lack of 
information of this system (MNPs-Tumor cell). 
With regard to the cytotoxicity studies, the determination of the cell viability of 
cultured tumor cells with MNPs by MTT essays were carried out. To that end, these 
experiments were realized modifying the concentration of MNPs and the times of incubation. 
The results showed that the cytotoxicity effect of the MNPs on the tumor cell lines studied is 
minimal, representing a net loss of cell viability about 20% in the range of MNPs 
concentration studied (0-200 µg mL-1), without causing any appreciable change over time. 
Studies related to the surface and intracellular distribution, of the MNPs treated-
tumor cells, were then realized. On the one hand, the affinity between MNPs and tumor cell 
lines was verified by Neubauer chamber counting, confirming that practically all cells attach 
the MNPs for each tumour line studied (PCI-13, MIA PaCa-2 and MDA-MB-231). On the 
other hand, thanks to an analysis of the intracellular distribution of the MNPs treated-tumor 
by SEM technique was corroborated that the cell line SH-SY5Y internalizes the MNPs. 
Besides, there appears to be that the MNPs alter the tumor cell morphology (a more complex 
cell surface pattern). 
Finally, the synthesis of the fully functional MNPs with highly specific markers and 
the CSCs targeting of these compounds, by fluorescence microscopies, was carried out. 
Primarily, the antibody-functionalized MNPs (MNPs:anti_CDs) was characterized in terms of 
stability and functionality, in basic media, obtaining a stable compound, for both anti-CDs 
(anti-CD44 and anti-CD44). Furthermore, it was observed as there seems to be an adequate 
MNP concentration, in this case around 50 µg mL-1, producing the MNPs agglomeration for 
higher concentrations and, thus, avoiding the interaction MNPs-anti-CDs. Finally, the 
targeting of CSCs with these previously synthesized complexes was evaluated. Thanks to this 
essay it was demonstrated, for the case of the SH-SY5Y, that the labeling of CSCs is 
successful only for the anti-CD44. Unfortunately, the CSCs targeting with the anti-CD133 
was not observed, possibly due to a functionalization loss because of the anti-CD133_PE was 
damaged.  
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These preliminary studies have provided us a clear idea of the difficulties that we 
face in the future if we go ahead with this ambitious project. On the one hand, the next step 
would be to improve the functionalization method used, trying to localize the CSCs with a 
good anti-CD133, in addition to carry out studies in more complex media. On the other hand, 
since there is no information available on whether hyperthermia can eradicate CSCs, our 
future challenges could be to evaluate if CSCs are sensitive to hyperthermia-induced by 
magnetic nanoparticles, and this may lead to control tumor growth (proliferation). 
Furthermore, it could also be examined if MHT increases sensitivity of cancer cells lines to 
chemo and radio therapy due to eradication of CSCs. 
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III. EXAMPLE 2: Regioselective control of molecular nanoprobes on filamentous 
virus particles and self-assembly of these functionalized rod-like nanoparticles 
 
1. INTRODUCTION 
 Viral nanoparticles (VNPs) form the basis of some novel renewable molecular 
materials due to many attractive features of the viruses such as a precise nanoscale 
dimensions, elasticity, stability, low polydispersity, biocompatibility and well known genetic 
information with an efficient and inexpensive production [1-3].  
1.1. M13 bacteriophage: wild type and mutant virus 
 The filamentous M13 bacteriophage [see the FIG. 1,2], an abundant virus in nature 
that infects the bacteria E. coli, is an ideal candidate for nanotechnology, among other features 
because it is non-enveloped, i.e. without a lipid membrane, so the functional groups on the 
capsid proteins can make direct contact with coating materials. General properties of these 
rod-shaped viruses include a length of about 900 nm, 6.5 nm in diameter, a molecular weight 
of 1.6x107 g mol-1 and a circular single-stranded DNA genome encased by several phage-
encoded proteins. The major protein capsid is a pVIII protein, where approximately 2700 of 
these coat proteins are helically wrapped to construct the flexible cylindrical body of the 
bacteriophage. At one end of this protein assembly, five copies of the pIII, a minor coat 
protein, form the tails of the phage that modulates phage infectivity of the host bacteria [4-6].  
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 These rod-like colloids can be handled easily in the laboratory and have long been 
used in molecular biology studies because they are amenable to genetic modification of virus 
capsid proteins. Besides, a very interesting characteristic of these VNPs is that non-reactive 
cysteine residues are exposed to exterior surface because evolution had disfavored 
interparticle disulfide bonds. Therefore, this presents a unique opportunity to genetically 
monitor the position of the cysteine residue on strategic locations of the virus and protein 
shells, after which the thiol group can be selectively targeted with thiol-selective probes [7]. 
 The mutant M13-C7C bacteriophage [see the FIG. 2] is based on a simple M13 
phage vector modified, in the end of the pIII protein, by pentavalent display of a loop-
constrained heptapeptide. Each loop is flanked by a pair of cysteine residues, which could be 
oxidized during the phage functionalization to a disulfide linkage. In this case, the infectivity 
function of PIII is not affected because the displayed peptide is sufficiently short (<50 
residues). Furthermore, the LacZ gene has been genetically inserted into the mutant phage 
vector, which is used as a characterization method to distinguish between the mutant M13-
C7C and the M13 (wild-type) phages thanks to the mutant phage plaques appear blue when 
plate on media containing XGal and IPTG. An important concept in biology is the plaque-
forming unit (PFU) which is a measure of the number of particles capable of forming plaques 
(colonies) per unit volume, such as virus particles. Unfortunately, there exists a 
counterproductive part resulting in a longer replication cycle of the mutant phage compared 
with the wild type. As a result, there is the possibility of in vitro selection for any 
contaminating wild-type phage during the amplification steps, even vanishingly small levels 
of contamination can result in a majority of the phage pool [8]. 
1.2. Liquid crystalline organization 
 ‘Soft’ matter, including polymers, colloids, amphiphiles, liquid crystals and a lot of 
biological systems, presents two fundamental features. The first one, the ordering is generally 
intermediate between that of a crystalline solid and that of a liquid, and the second one is the 
range of organization shown in the structures formed, typically in the ‘nanoscale’ ordering (1-
1000 nm). An important distinction between different types of soft material is the difference 
between direct and indirect ordering of molecules via supramolecular aggregates [9]. 
 Liquid crystals are materials presenting at least one intermediate phase between 
isotropic liquid and crystalline solid phases. The calamitic liquid crystals are the most 
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common type of self-assembly for these structures, composed exclusively of anisotropic 
particles exhibiting a rod-shape. Liquid crystals composed of rod-like colloids exhibit 
different phase sequences with increasing concentration, behaving as lyotropic liquid crystals. 
The simplest liquid crystalline phase is the so called nematic (N), in which the molecules are 
positionally totally disordered, but arrange in a same preferential direction. The Smectic (Sm) 
phase shows a positional order since the centres of mass are arranged in layers (Sm layers) 
[see the FIG. 3] [10-12]. 
  
1.3. Applications of the virus-based hybrid materials 
 There exists an ample utilization of the phage display technology for material science 
applications. Liquid crystalline self-ordering systems with nanosized features of engineered 
viruses may provide new pathways to organize electronic, optical, and magnetic materials that 
would not be feasible via the traditional top-down fabrication techniques [3, 13]. For example, 
the wire-structures of viruses have inspired studies of their applications as conductive 
nanowires for electrical devices such as nanocircuits or nanobatteries, by mineralizing 
continuous metal layers on the virus surface, to obtain nanowires that exhibit crystallographic 
ordering [4]. Also, studies of the use of rod-like viruses as biological scaffolds for the 
construction of light-harvesting systems or magnetic systems are noteworthy both for their 
potential uses in solar cells, photocatalysts, and optical sensors or memory devices, 
respectively [see the FIG. 4 (left)] [5].  
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  More recently, nanometer-sized constructs, such as dendrimers, liposomes, 
nanoshells, nanotubes, nanoemulsions, quantum dots, and even viruses are being developed to 
increase detection sensitivity and efficacy for therapeutic applications as bioimaging agents 
intended as noninvasive probes (near infrared fluorescent dyes, magnetic contrast agents) or 
to target biomarkers of disease [7, 14]. For example, the crystalline phase of the VNPs could 
be adjusted to create enhanced suspension stability for magnetic resonance imaging (MRI) 
contrast agents [5]. Also, the VNPs could be an invaluable tool to improve detection, early 
and accurate biosensing, of small lumps of cancer cells. These “smart” nanoparticles were 
equipped with bright fluorescent dyes for imaging and a chemical tags to help it find and latch 
onto cancer cells to increase imaging sensitivity [see the FIG. 4 (right)] [15]. 
 
2. AIMS 
  The validation of a method to carry out the mass production of the mutant M13-C7C 
phages and the optimization process to functionalize with any maleimide probe are reviewed 
in this work: 
-   Amplification, purification and characterization of the M13-C7C phages. The growth 
of viruses by M13-C7C-infected bacteria solution and analysis of the phages obtained, by 
titration process and transmission electron microscopy (TEM), will be carried out. 
-  To functionalize phages with nanoprobes. The functionalization of these rod-like 
particles, with a previously disulfide reduction process, and labeling with maleimide-
functionalized fluorophores of the M13-C7C phage will performed. 
-    Self-organization studies. Liquid crystal line phases will be studied by fluorescence and 
differential interference contrast microscopy (DIC), in order to validate our scientific 
approach, i.e. the regioselective functionalization of viral nanoparticles (VNPs). 
 
3. EXPERIMENTAL SECTION 
▫ Note: In the APPENDIX 2 are shown some protocols for working with phages. 
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3.1. Precautions. It is important to note the special precautionary measures that were taken 
into account in every step before and during the amplification process always to prevent the 
contamination of the mutant viruses with the undesired wild-type ones. Basically, the 
multiplication of the wild type is many times greater than the mutant viruses and consequently 
the slightest contamination would lead a guaranteed failure. Therefore, the first step was to 
disassemble and thoroughly clean the micropipettes with 70% EtOH, which were used 
exclusively in the inoculation processes. Besides, some considerations such as the thorough 
cleaning of the laminar hood with 70% EtOH every time was used, the use of virgin bacterial 
culture Petri dish without a previous bacteria extraction or the opening of a new box of 
aerosol-resistance tips for each new amplification, were strictly undertaken [8]. 
3.2. M13-C7C amplification process. A volume of LB was inoculated with the mutant M13-
C7C solution at a concentration of 1011 pfu mL-1 (1mL/L for the infecting solution and 0.5 
mL/L for the mass production). At the same time, a volume of E. coli ER2738 culture 
(10mL/L for both cases), previously grown overnight, were also added. The mix was shaken 
at 37ºC, 230 rpm for different incubation times (5 hrs for the infecting solution and 8 hrs. for 
the mass production) [8, 16]. 
3.3. M13-C7C titration process. Firstly, 200 µL of serial dilutions of M13-C7C phage in LB 
were prepared into sterile tubes. After, 200 µL of E. coli ER2738 (OD599=0.5) were put into 
each one of the M13-C7C serial dilutions, vortex and incubate for 5 min at room temperature. 
Then, 3 mL of top agar at 56ºC were also added, vortex and the mix were poured on the top of 
the IPTG/XGal_LB-agar plates prepared previously. Finally, let cool down, cover with 
parafilm and grow overnight at 37ºC [8, 16]. 
3.4. Functionalization process. 50 mL of the M13-C7C mass production (1 mg mL-1) in 20 
mM Na2HPO4 buffer pH 7.0 was reduced with 1.22 µM TCEP·HCl about 30 min at room 
temperature. Then, the solution was mixed with 3.05 µM of DyLight 550 Maleimide (1 mL of 
DyLight 550 Sulfhydryl-Reactive Dye purchased from the Thermo Scientific Company) 
dissolved in DMSO, 1:104 dilution to prevent virus damage, stirring gently it at 4ºC for 2 hrs. 
It must be taken into account that is needed 10 times more of reduction agent and dye per 
virus molecules, because there are 5 tails per M13-C7C molecule with 1 disulfide group in 
each tail. Besides, it has been used about 2 and 8 molar excess of reduction agent and dye, 
respectively [17-19]. 
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4. RESULTS AND DISCUSSION 
▫ Note: In the APPENDIX 2 are shown some photos taken during the course of the project. 
4.1. BIOLOGY 
  Before starting the experiments, a 1:100 dilution of the M13-C7C bacteriophage (100 
mL of Ph. D.-C7C [phage display Library], ~1013 pfu mL-1, purchased from the New England 
Biolabs Company) was prepared, because a 1011 pfu mL-1 value is required for the 
amplification process. 
  The first step was to prepare 50 mL of the infecting solution, corresponding to a first 
amplification, needed to carry out subsequently the M13-C7C mass production. It was 
mandatory to check the complete absence of wild type viruses (M13 phages) in the infecting 
solution before to proceed with the following steps. In the FIG. 5 are shown four filamentous 
phages with an estimated length of 1006 nm (accomplished by Alexis de la Cotte of the 
CRPP). Many impurities are observed in the picture due to the LB medium drying. 
  
  An optimization process was now realized to optimize the steps of multiplication and 
purification needed for the mass production. Specifically, Optical Density (O.D.) 
measurements at different incubation times were taken to study the bacteria growth curve [see 
the FIG. 6]. Viruses need to infect bacteria to multiply. Therefore, virus amplification also 
occurred during bacterial amplification, corresponding to the exponential phase. The results 
indicate that the exponential phase before it reaches the plateau (stationary phase) is between 
4 and 10 hrs. It should be noted that the probability of infecting the amplification solution 
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with the wild type viruses increases with incubation time, due to a higher number of 
mutations. After several amplifications essays, it was confirmed that a suitable amplification 
time is 8 hrs. Besides, the purification process was also maximized, adapting the 
centrifugation steps (times and speeds) [see the FIG. 7]. 
  Once the process was optimized, the M13-C7C mass production was carried out to 
produce the M13-C7C in huge amounts. For do that, 10 independent experiments of 
amplification with a final volume of 2 L were made to obtain about 284 mg of the mutant 
M13-C7C phage, free from wild type (see the experimental section 3.2.). 
  A purification process of the M13-C7C phages is needed to carry out after each 
amplification process. This process is composed of a depletion step and several centrifugation 
steps [see the FIG. 7], which aims is obtain the M13-C7C in high concentration diluted in 
dH2O and free of bacteria, LB and other impurities.        
 
  These last two processes, the amplification and purification, are the most important 
steps in the work, consequently where more time has been invested, because a large-scale 
production of pure mutant M13-C7C viruses is necessary to form smectic phases of liquid 
crystals. 
 
  
   
  Finally, a checking process by titration was carried out for each sample amplified 
(explained in the experimental section 3.3.) to corroborate that the amplification had been 
successful [see the FIG. 8]. Specifically, this characterization process allows to know both 
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whether or not the amplified culture is infected, by the wild type M13, and the PFU mL-1 
value. 
 
 
  The results achieved were satisfactory, even exceeding our expectations, obtaining 
considerable amounts of M13-C7C with only blue colonies in all plates. To confirm of 
absolutely way that the viruses correspond exclusively to mutant M13 an amplification of 
DNA is suggested [8]. But this process is only suitable when it works with analytical 
quantities. Therefore, the functionalization of the mutant M13-C7C bacteriophages with 
fluorescent probes and the study the liquid crystalline phases obtained will be done to confirm 
in a definitive way these biological results. 
  
4.2. CHEMISTRY  
The second part, the chemistry, a functionalization method was proposed both to 
validate the amplification process, to verify this once and for all and also to validate this 
functionalization method. 
  After the functionalization process [see the FIG. 9], composed of a first reduction 
step of thiol groups and another corresponding to the labeling with the 550 maleimide dye 
(explained in the experimental section 3.4.), two dialysis processes were carried out. Firstly, 
with dH2O to remove the excess of dyes and the second with 20 mM TRIS, pH 8.1, 20 mM 
NaCl, to change the pH for suitable working conditions with virus liquid crystals. 
 
  It is noted that in this purification step, corresponding to dialysis step, did not work 
to remove the excess of dyes for both dH2O and TRIS buffer. This is because a pink solution, 
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corresponding to the dye color in solution, was not obtained after the first dialysis step. 
Despite that, the dialysis process is needed to remove protein remains and other impurities 
that are impossible to remove by centrifugation. Therefore, to overcome this obstacle and to 
remove the excess of dye, several ultracentrifugation steps were carried out.  
 
4.3. PHYSICS  
  An ultracentrifugation process was fundamental, in any case, to concentrate the 
viruses for the sample preparation. Working with liquid crystals, and study the smectic (Sm) 
phases, must be achieve concentrations around 90-140 mg mL-1 of virus. To do this, the 
sample preparation is a delicate and laborious process, because we need homogeneous sample 
which is highly concentrated. The iridescence phenomena, due to visible light diffraction of 
the smectic layers (having a periodicity of about 1 µM), were observed within the sample 
once a homogenous smectic phase is achieved [see Appendix, the Image 12]. 
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  Self-organization studies. Three images of the smectic phases, using different 
observation conditions, in two different zones were taken by confocal microscopy [see the 
FIG. 10].  Clear lines are observed by differential interference contrast (DIC) microscopy. 
Each line corresponds to a layer of virus with a width of the size of the M13 virus (1.006 µm). 
Two different results are obtained when the fluorescence is measured. On the one hand, 
exciting at 550 nm our 550 DyLight emits red light, showing the functionalized tails colored. 
On the other hand, it is not observed the pattern of lines in the sample when the sample is 
excited at 488 nm. This confirms that the goal has been achieved, obtaining phages 
functionalized with fluorophores with a regioselective control. Besides, thanks to this 
functionalization step it could verify that the amplification process was a success. 
  An important consideration, constituting the most direct application of our results, is 
that an optical technique more easily available in any lab, such as fluorescence microscopy, 
can be now used to study these self-organization structures. Therefore, it is not already 
necessary to use an advanced technique, such as DIC, to observe the Sm or lamellar phases 
whenever working with these fluorescence mutant M13-C7C viruses. 
   
5. CONCLUSIONS 
 A simple approach for the mass production of mutant M13-C7C viruses by 
amplification process, free of the wild type, is described. The main advantage of this M13-
C7C amplification process is the large-scale production of the mutant phages exhibiting 
cysteine residues at one of its extremities. However, the special precautionary measures to be 
taken to avoid any contamination with the wild type viruses, before and during the 
amplification process, are strong. Herein lies the importance of this method validated, namely 
the neatness worked with over the life of this project. 
 With regard to the biology part, the first challenge was to obtain the infecting 
solution, without the M13 viruses, and perform the optimization process. Secondly, the 
multiplication processes, with the corresponding purification steps, were carried out many 
times until a sufficient quantity of mutant viruses were reached. The results achieved were 
more than satisfactory obtaining considerable amounts of mutant M13-C7C viruses. To do 
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this, a checking process by titration was carried out, obtaining exclusively blue colonies for 
each phage dilution on every plate.  
 The chemistry section consisting in a method of functionalization was then realized, 
achieving the validation of this method as well as definitively the amplification process also. 
To do this, a first reduction step of thiol groups and another corresponding to the labeling 
with a maleimide dye, with the corresponding purification steps, were realized. 
 Finally, related to the physics part, the self organization studies of these 
functionalized rod-like nanoparticles were carried out. To that end, the sample was prepared 
through a delicate process. Three images of the smectic phases, using different conditions, 
were taken by confocal microscopy. Bright lines, each corresponding to a layer of virus were 
observed by differential interference contrast (DIC) microscopy. Two different results, 
exciting at 550 nm or 488 nm, were obtained when the fluorescence was measured, showing 
the functionalized tails colored due to a pattern in the sample or  non-pattern observed, 
respectively. This confirms that the aim was achieved, obtaining phages functionalized with 
fluorophores with a regioselectivity control. 
 
  Over the years noticeable advances are being made in the fabrication of nanostructured 
novel materials from VNPs due to the unique capabilities of the viruses, such as high 
monodispersity, chemical specificity and the anisotropic character. We anticipate that our 
approach, using a liquid crystalline self-ordering system of engineered mutant viruses, may 
provide new pathways to organize electronic, optical, and magnetic materials among other 
potential applications. Therefore, our next challenge could be to develop hybrid materials 
formed by the monitored assembly of these mutant M13-C7C phages with magnetic 
nanoparticles, with a 1:1 molar ratio, to induced highly sensitive nanorods by magnetic field. 
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IV. GENERAL CONCLUSIONS 
 
Those conclusions specifically related to the results from each subsections (i.e., 
CSCs and viral particle functionalization) have been already exposed at the end of the 
corresponding chapters. Here, the general conclusions from the whole work are to be 
presented.  
The work realized along this Final Master project can be evaluated within the 
framework of two independent research lines on the functionalization of nanoprobes for 
biomedical or technological applications, respectively.  
A first, methodological consideration based on the work and discussions found along 
several months of this work, refers to the multidisciplinary nature of the research presented 
here. This multidisciplinary character of our work is the fundamental reason why it has been 
developed at several different research groups, which were formed by physicists, chemists, 
biochemists and medical doctors. 
The relevance of the nano-object based functionalization has become clear in both 
applications reported here: 
On one hand, with regard to the functionalization method chosen for application to 
cancer stem cells, the ‘simple’ electrostatic interactions tuned by adjusting the pH gave 
satisfactory results regarding the functionalization of the MNPs with the anti-CDs.                 
If more complex essays are to be performed in the future (e.g., further change to cRPMI 
medium or for the actual in vivo conditions), then a more appropriate strategy should be to 
change for a more robust attachment of the functional groups, such as avidin-biotin or 
maleimide-thiol binding. 
Regarding the second example, i.e. the functionalization of viral particles, the 
maleimide-thiol functionalization has proven to be an excellent method. The advantages of 
this method include a strong attachment (covalent bond), high selectivity (reacting exclusively 
with thiol groups), stability in extreme conditions and simple experimental protocol (it has 
been developed as a single-step protocol). 
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It is clear that the age of the nanobiotechnology has just begun. The increasing 
complexity of diverse materials involving multiple scales, the combination of rational design 
and evolution, and the emerging confluence of bio and nano are broad technological trends 
that will give great momentum to nanobiotechnology in the coming years. 
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○ ABBREVIATIONS: 
 
AB: Monoclonal antibody (specific) 
anti-CD: Monoclonal antibody (specific) 
anti-CD_FLU: Fluorophore conjugated to anti-CD  
anti-CD44: CD44 (HI44a) Antibody 
anti-CD44_FITC: FITC conjugated to CD44 antibody 
anti-CD44_PE: PE conjugated to CD44 antibody 
anti-CD133: CD133/1 (AC133) Antibody 
anti-CD133_FITC: FITC conjugated to CD133/1 antibody 
anti-CD133_PE: PE conjugated to CD133/1 antibody 
CD: Surface Cell Receptor or Antigen (CD44 or CD133) 
CD44: A highly glycosylated type-I transmembrane cell surface receptor protein 
CD133: A glycosylated transmembrane cell surface antigen 
cRPMI: Complete medium 
CSCs: Cancer Stem Cells 
DAPI:  4',6-diamidino-2-phenylindole 
DIC: Differential Interference Contrast 
DMF: N,N-Dimethylformamide 
DMSO: Dimethyl sulfoxide 
FcR: Fc receptor 
FITC: Fluorescein isothiocyanate 
FLU: Fluorophore (FITC or PE) 
IPTG: Isoprophyl thiogalactoside, or isopropyl β-D-galactopyranoside 
LB: Luria-Bertani broth 
M13: A wild-type filamentous bacteriophage 
M13-C7C: A mutant form of the M13. 
MDA-MB-231: Breast cancer cell line 
MHT: Magnetic Hipertermia 
MIA PaCa-2: Pancreatic cancer cell line 
Milli-Q: Ultrapure water of type 1 
MNP: Magnetic Nanoparticle 
MNPs:anti-CD: MNPs conjugated to an anti-CD 
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MNPs:anti-CD_FLU: MNPs conjugated to an anti-CD_FLU 
MNPs:anti-CD133_FITC: MNPs conjugated to an anti-CD133_FITC 
MNPs:anti-CD133_PE: MNPs conjugated to an anti-CD133_PE 
MNPs:anti-CD44_FITC: MNPs conjugated to an anti-CD44_FITC 
MNPs:anti-CD44_PE: MNPs conjugated to an anti-CD44_PE 
MRI: Magnetic Resonance Imaging 
MTT: 3-(4-5-Dimethylthiazol-2-yl)-2,5-diphenyltretazolium bromide 
NP: Nanoparticle 
PBS: Fetal Bovine Serum 
PCI-13: SCCHN cell line 
PE: R-Phycoerythrin 
PEG: Polyethylene glycol 
PEI: Polyethylene imine 
PFA: Paraformaldehyde 
PFU: Plaque-forming unit 
RPMI: Roswell Park Memorial Institute medium 
RT: Room temperature 
SCCHN: Squamous Cell Carcinoma of the Head and Neck 
SEM: Scanning Electron Microscopy 
SH-SY5Y: Human neuroblastoma cell line 
Sm: Smectic phase 
TCEP: Tris-(2-carboxyethyl)phosphine hydrochloride 
TEM: Transmission Electron Microscopy 
TRIS: Tris(hydroxymethyl)aminomethane 
VNPs: Viral Nanoparticles 
XGal: 5-Bromo-4-Chloro-3-indolyl-β-D-Galactopyranoside 
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■ APPENDIX 1 
▪ PROTOCOLS FOR WORKING WITH TUMOR CELLS 
The following steps were undertaken whenever a new essay with tumor cells was launched. 
• Some important considerations to take into account when working with cell lines: 
-   Pre-warmed culture medium and PBS at 37ºC are used. 
-  It must work under sterile conditions within laminar flow hood whenever an incubation 
process is carried out later. Therefore, it is also obligatory to use sterile material and 
sterilized solutions in these cases. 
-  The cell samples with MNPs must be treated very careful because even the slightest jolt 
could produce the detachment of cells, because of the shearing stress caused by the MNPs. 
-  cRPMI: The following compounds must be added to each new RPMI 1640 bottle (Sigma-
Aldrich): 10% PBS, 1% L-glutamine, 1% Penicillin/Streptomycin solutions, 1% MEM 
non-essential amino acid and 1% Sodium pyruvate (100 mM).  
• Preservation (or storage) and thawing of tumor cell lines 
Liquid nitrogen is used to preserve cultured tumor cells to -196°C. To minimize the 
effects of freezing, a cryoprotective agent which lowers the freezing point, DMSO, is added. 
It was used a typical freezing medium composed of 90% serum and 10% DMSO. 
The frozen samples of cultured tumor cells were thawed by placing the vials directly 
into a 37°C water bath. As soon as the last ice crystal was melted, the cells were immediately 
diluted into medium. These tubes have to be centrifuged for 5 min at 1500 rpm to eliminate 
the toxic agent, DMSO.  Finally, the supernatant was removed by decantation and the pellet 
resuspended in cRPMI. 
• Maintenance of tumor cell lines 
Tumoral cells are grown and maintained at 37°C with 5% CO2 into a humified 
incubator. Cell culture flasks should be examined daily, observing the morphology, the color 
of the medium and the density of the cells. Normally, because of cell growth, medium is 
replaced every two or three days. In this period of time is observed a change of color of red-
rose to yellow-brown. 
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• Harvesting of tumor cell lines (standard protocol for adherent cells) 
Tumor cells, a type of adherent cells, are harvested when have reached a too much 
population density or it is interested in carrying out an essay. 
Firstly, it was removed and discarded the spent cell culture medium from each culture flask 
and proceeding with the wash step, without wasting any time to prevent cell drying. To this 
end, PBS (wash solution) was gently added on the opposite side of the attached cell layer of 
the vessel to avoid disturbing it, and rock the vessel back and forth several times (repeat twice 
in total). This wash step removes any traces of serum, calcium, and magnesium, apart of dead 
cells or other impurities, that they would inhibit the action of the dissociation reagent. 
Secondly, it was removed and discarded the wash solution from each culture vessel and was 
added the pre-warmed accutase (trypsin) into the tumor cells. This is a dissociation reagent to 
disengage the cells from the vessel. It was used enough reagent to cover the cell layer, gently 
rocking the container to get complete coverage of the cell layer. It now was incubate the 
culture vessel at 37º for 3-7 min (the actual incubation time varies with the cell line used) to 
facilitate cell separation. In difficult cases, it can tap the vessel to expedite cell detachment. 
Thirdly, once cells were been detached, it was added the equivalent of twice the volume used 
for the dissociation reagent of pre-warmed complete growth medium to neutralize the trypsin 
effect. It was dispersed the medium by pipetting over the cell layer surface several times. 
Then, tumor cells were transferred to a conical tube and were centrifuged, at 200 × g during a 
few minutes (about 7 min), for removing pollutants. 
Finally, the cell pellet was resuspended in a minimal volume, depending on the estimated cell 
density, of pre-warmed cRPMI for cell counting. 
• Counting of tumor cells 
It is essential to know the tumor cell concentration for each sample before carrying 
out an experiment, to work with the appropriate conditions and obtaining reproducible essay. 
Therefore, 100 µL of tumor cell sample are removed and mixed 1:1 with 4% trypan blue 
solution, a diazo dye, which distinguishes between dead and living cells. Viable cells, with 
intact cell membranes, exclude trypan blue while dead cells stain blue due to trypan blue 
uptake. Then, the total number of cells is calculated using a hemacytometer. This is a 
counting chamber which determines the cell concentration in a liquid sample. 
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FLUORESCENCE IMAGES OF THE CYTOTOXICITY ESSAYS. 1) Blank (only MNPs): 1.a)  
0 µg mL-1, 1.b) 100 µg mL-1. 2) MNPs_MDA-MB-213_12h: 2.a) 0 µg mL-1, 2.b) 5 µg mL-1, 2.c) 5 µg 
mL-1, 2.d) 100 µg mL-1. 3) MNPs_MIA PaCa-2_36h: 3.a) 0 µg mL-1, 3.b) 50 µg mL-1, 3.c) 100 µg 
mL-1, 3.d) 200 µg mL-1. 4) MNPs_PCI-13_60h: 4.a) 0 µg mL-1, 4.b) 50 µg mL-1, 4.c) 100 µg mL-1, 
4.d) 200 µg mL-1. Images taken by the inverted fluorescence microscope AXIOVERT 40 CEL in the 
image service of the Hillman Cancer Center (Pittsburgh, USA). 
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▪ FLUORESCENCE IMAGES OF THE SH-SY5Y TUMOR CELL LINE. A) Study of the 
interaction between MNPs:anti_CDs in TRIS buffer, pH:7.9. SUPERNATANTS: cells + 5 µL of 
each anti CDs + MNPs. A.1) 5 µg mL-1 MNPs: A.1.a) Without filter, A.1.b) Green filter, A.1.c) Red 
filter. A.2) 25 µg mL-1 MNPs: A.2.a) Without filter, A.2.b) Green filter, A.2.c) Red filter. A.3) 100 µg 
mL-1 MNPs: A.3.a) Without filter, A.3.b) Green filter, A.3.c) Red filter. B) Preparation samples for 
SEM. B.1) BLANK1 (only cells): B.1.a) cells, 20X, B.1.b) cells, 40X. B.2) BLANK2 (cells + MNPs): 
B.2.a) 1 µg mL-1 MNPs, B.2.b) 5 µg mL-1 MNPs, B.2.c) 25 µg mL-1 MNPs, B.2.d) 100 µg mL-1 
MNPs. Images taken by the inverted fluorescence microscope NIKON ECLIPSE TE2000-S in the 
image service of the INA. 
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■ APPENDIX 2 
▪ BASIC PROTOCOLS FOR WORKING WITH PHAGES 
 
• Culture media 
- LB-Agar plates: To prepare 5 plates: 100 mL of pre-warmed LB-Agar (5 plates per 100 
mL), warming up in the microwave, is poured in every plate, filling 1/3 of the plate, and 
wait to solidification. Store the plates upside down wrapped with parafilm, to prevent them 
from drying out, and store at 4ºC. 
- IPTG/XGal_LB-agar plates. To prepare 25 plates: 0.1 mM of IPTG and XGal (corresponds 
to 100 µL/200 µL of 0.1 M IPTG/0.05 M XGal stock solution, respectively) were added 
into 100 mL of LB-Agar (8 plates per 100 mL), previously dissolved and cooled to 65ºC or 
less. As quickly as possible after their preparation, the solution is poured into the plates, 
until cover the surface completely, and wait to solidification. Store the plates upside down 
inside the bag at 4ºC. 
 
• Culture bacteria 
- Preparation of plating bacteria: To prepare 3 E.coli_LB-Agar plates: Streak out the master 
stock culture of E. coli K12 ER2738 onto each LB-Agar plate, helped by a sterile stick. 
Then, the plates were inverted and incubated at 37ºC overnight. Store for a maximum of 2 
weeks, wrapped with parafilm at 4ºC in the dark. 
- Preparation of bacteria solution: To prepare 100 mL of E.coli_LB solution: Firstly, 100 mL 
of LB were inoculated, in a 100 mL sterile erlenmeyer, with a  single well-isolated 
bacterial colony, picked from the minimal agar plate previously prepared. Then, 133 µL of 
Tetracycline (7.5 mg mL-1) were added to the solution. Tetracycline is a broad-spectrum 
polyketide antibiotic (explain). Finally, the liquid culture was agitated, in a rotatory shaker, 
overnight at 37ºC and 180 rpm. 
 ▫ Note: It must work in the amplification process with values of OD around 0.5 for the 
bacteria solution, because this corresponds at the beginning of the exponential phase. 
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▪ PHOTOS TAKEN DURING THE COURSE OF THE PROJECT. 1) PREPARATION OF 
PLATING BACTERIA: E.coli K12 ER 2738 grown in LB medium. 2) PREPARATION OF 
SOLUTION BACTERIA: Turbid solution after overnight incubation. 3) AMPLIFICATION 
PROCESS: Incubation process. 4) PURIFICATION PROCESS: Step 1_Elimination bacteria-Plastic 
bottles with the bacteria pellets after the centrifugation process. 5) PURIFICATION PROCESS: Steps 
2-3_Comparation between both samples: after the depletion process (turbid solution) and after the 
step3-erlemeyer containing the supernatant removed (clear solution). 6) TITRATION PROCESS: 
Preparing the phage dilutions. 7) TITRATION PROCESS: Let cool down the IPTG/XGal-LB agar 
plates with the top agar-dilutions samples. 8) SAMPLE PREPARATION FOR SEM: M13-C7C 
sample and washing solutions. 9) FLUORESCENCE LABELLING PROCESS: Removing the excess 
of dye by centrifugation process. 10) SAMPLE PREPARATION FOR LIQUID CRYSTALS 
STUDIES: Melting the ends of capillary to seal hermetically. 11) SAMPLE PREPARATION FOR 
LIQUID CRYSTALS STUDIES: Sealing the sides of sample with UV polymer glue. 12) SAMPLE 
PREPARATION FOR LIQUID CRYSTALS STUDIES: Iridescence phenomena observed within the 
sample with Sm phase organization. All Photos were taken at the Centre de Recherche Paul Pascal 
(CRPP-CNRS), Bordeaux, France.  
